Dinoprostone Vaginal Insert for Induction of Labor in Women with Low-Risk Pregnancies: A Prospective Study
- PMID: 35422562
- PMCID: PMC8976886
- DOI: 10.5455/medarh.2022.76.39-44
Dinoprostone Vaginal Insert for Induction of Labor in Women with Low-Risk Pregnancies: A Prospective Study
Abstract
Background: Induction of labor (IOL) is a technique to establish vaginal delivery when the risks for continuing the pregnancy for mother or baby are higher than the risks of delivery. It is usually performed in high-risk pregnancies, but can also be beneficial in low-risk populations, as shown in the ARRIVE trial.
Objective: To evaluate the effectiveness and safety of slow-release vaginal dinoprostone (prostaglandin E2 10 mg) for labor induction in women with low-risk pregnancies.
Methods: A prospective study was performed at Hanoi Obstetrics and Gynecology Hospital, Vietnam. We recruited women with low-risk pregnancies from 39 weeks + 0 days to 40 weeks + 6 days of gestation and an unfavorable cervix. Women who participated received 10 mg intravaginal slow-release dinoprostone (Propess) for induction of labor. Labor, deliveries, and post-partum management were performed according to the local protocol.
Results: From September 2020 to March 2021, 102 low-risk women were eligible to participate in the study. Among these women, 67.6% had vaginal deliveries, 6.9% had postpartum bleeding, and 3.9% experienced tachysystole. All newborns were healthy, with good APGAR scores. None of the women needed respiratory support or intensive care unit admission. All other maternal or fetal complications were explored. The rate of cesarean section was 3.8 higher in nulliparous than multiparous women and 2.2 times higher in women who did not receive epidural analgesia than in those who did. The risk of cesarean section increased if the time between labor induction and active labor was greater than 12.5 hours.
Conclusion: Slow-release dinoprostone insert is safe and effective for the induction of labor in low-risk pregnant women. The risk of cesarean section was elevated in nulliparous patients and those who did not receive epidural analgesia during labor. As the time from labor induction to active labor increased, the risk of cesarean section increased.
Keywords: dinoprostone; induction; labor; low-risk; vaginal.
© 2022 Nguyen Duy Anh, Tran Anh Duc, Nguyen-Thi Thu Ha, Duong-Thi Tra Giang, Do Tuan Dat, Phan-Thi Huyen Thuong, Nguyen Khac Toan, Nguyen Tai Duc, Nguyen Minh Duc.
Conflict of interest statement
The authors declare that there is no conflict of interest
Figures
Similar articles
-
Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.Arch Gynecol Obstet. 2009 Jul;280(1):19-24. doi: 10.1007/s00404-008-0843-9. Epub 2008 Nov 26. Arch Gynecol Obstet. 2009. PMID: 19034471 Clinical Trial.
-
Transcervical Foley balloon catheter and vaginal prostaglandin E2 insert combination vs. vaginal prostaglandin E2 insert only for induction of labor at term: a randomized clinical trial.Arch Gynecol Obstet. 2019 Feb;299(2):451-457. doi: 10.1007/s00404-018-4998-8. Epub 2018 Dec 7. Arch Gynecol Obstet. 2019. PMID: 30536117 Clinical Trial.
-
Induction of labor at term with vaginal misoprostol or a prostaglandin E2 pessary: a noninferiority randomized controlled trial.Am J Obstet Gynecol. 2021 Nov;225(5):542.e1-542.e8. doi: 10.1016/j.ajog.2021.04.226. Epub 2021 Apr 19. Am J Obstet Gynecol. 2021. PMID: 33887241 Clinical Trial.
-
Double-balloon catheter vs dinoprostone (PGE-2) insert for labour induction: A meta-analysis of 2493 pregnancies.Afr J Reprod Health. 2023 Apr;27(4):84-95. doi: 10.29063/ajrh2023/v27i4.10. Afr J Reprod Health. 2023. PMID: 37584912 Review.
-
Recent advances in the induction of labor.F1000Res. 2019 Oct 30;8:F1000 Faculty Rev-1829. doi: 10.12688/f1000research.17587.1. eCollection 2019. F1000Res. 2019. PMID: 31723412 Free PMC article. Review.
Cited by
-
Results of Induction of Labor with Prostaglandins E1 and E2 (The RIPE Study): A Real-World Data Analysis of Obstetrical Effectiveness and Clinical Outcomes of Pharmacological Induction of Labor with Vaginal Inserts.Pharmaceuticals (Basel). 2023 Jul 8;16(7):982. doi: 10.3390/ph16070982. Pharmaceuticals (Basel). 2023. PMID: 37513894 Free PMC article.
-
A Retrospective Comparative Study of the Effect of Controlled-Release Dinoprostone Vaginal Delivery System (Propess®) and Mechanical Methods for Cervical Ripening in Nulliparous Women in Late-Term Pregnancy.Cureus. 2023 Oct 18;15(10):e47255. doi: 10.7759/cureus.47255. eCollection 2023 Oct. Cureus. 2023. PMID: 37859678 Free PMC article.
-
Safety of the use of dinoprostone gel and vaginal insert for induction of labor: A multicenter retrospective cohort study.Int J Gynaecol Obstet. 2025 Mar;168(3):1039-1046. doi: 10.1002/ijgo.15952. Epub 2024 Oct 14. Int J Gynaecol Obstet. 2025. PMID: 39400318 Free PMC article.
References
-
- Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med. 2018 Aug 9;379(6):513–523. doi: 10.1056/NEJMoa1800566. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials